What is the evidence for viscosupplementation in the treatment of patients with hip osteoarthritis? Systematic review of the literature.

Author: LammeBas, MulierMichiel, SermonAn, van den BekeromMichel P J

Paper Details 
Original Abstract of the Article :
Osteoarthritis (OA) is a disease of the synovial joints and is the most common cause of chronic pain in the elderly. One of the treatment modalities for OA of the hip is viscosupplementation (VS). Today there are several different formulations of viscosupplements produced by different manufactures o...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s00402-007-0447-z

データ提供:米国国立医学図書館(NLM)

Viscosupplementation: A Treatment for Hip Osteoarthritis?

Osteoarthritis (OA) is a common joint disorder, especially in the elderly. It can be like a relentless desert wind, causing pain, stiffness, and limited mobility. Researchers are exploring various treatment options to alleviate the symptoms and improve quality of life for those with OA. This systematic review investigates the efficacy of viscosupplementation (VS) in treating hip OA.

Viscosupplementation: A Potential Oasis in the Desert of OA Treatment

The review assesses the current literature on VS, a treatment that involves injecting hyaluronic acid into the affected joint. While the results are mixed, some studies suggest that VS may provide short-term pain relief and improve joint function. However, the long-term effectiveness and optimal VS formulations remain unclear.

More Research Needed to Guide Treatment Decisions

This review highlights the need for more comprehensive research to determine the true effectiveness of VS for hip OA. Like a desert explorer seeking a reliable water source, clinicians need clear evidence to guide treatment decisions. Further research is essential to establish the optimal VS formulations, identify appropriate patient populations, and assess long-term outcomes.

Dr.Camel's Conclusion

This review leaves us with a few questions in the desert of OA research. While VS may offer some temporary relief, more research is needed to confirm its long-term effectiveness and identify the best applications for this treatment. We need to continue our journey for a truly lasting solution for hip OA.

Date :
  1. Date Completed 2008-12-16
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

17874246

DOI: Digital Object Identifier

10.1007/s00402-007-0447-z

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.